A Vaccine by November? Science Journalist in Vaccine Trial Casts Doubt on Rosy U.S. Projections

With 30,000 people taking part in the first major COVID-19 vaccine study in the United States, hopes are high that the collaboration between drugmaker Moderna and the National Institutes of Health will yield positive results as early as November. Researchers around the world are working on more than 165 vaccine candidates, though only a handful are conducting large-scale human trials. We speak with BBC science journalist Richard Fisher, who took part in the vaccine trial run by Oxford University that is among the most promising. It was both a personal decision and a journalistic one," Fisher says of his decision to volunteer. I wanted to do something that helps the collective effort to get us closer to a vaccine."